{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:00:29Z","timestamp":1775880029202,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2022\/SS10\/USM\/02\/7"],"award-info":[{"award-number":["FRGS\/1\/2022\/SS10\/USM\/02\/7"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06286-0","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:42:26Z","timestamp":1762166546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohamad Qazreen","family":"Ahmad Shawaludin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarina Thasneem","family":"Zainudeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahisham","family":"Taib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azlan","family":"Husin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adli","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intan Juliana","family":"Abd Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"July","key":"6286_CR1","first-page":"1","volume":"14","author":"S Vanselow","year":"2023","unstructured":"Vanselow S, Wahn V, Schuetz C. Activated PI3K\u03b4 syndrome \u2013 reviewing challenges in diagnosis and treatment. Front Immunol. 2023;14(July):1\u201312.","journal-title":"Front Immunol"},{"issue":"3","key":"6286_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","volume":"59","author":"M Jamee","year":"2020","unstructured":"Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, \u0648\u0622\u062e. Clinical, Immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2020;59(3):323\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"6286_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2900","volume":"46","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Genet. 2014;46(5):440\u20136. https:\/\/doi.org\/10.1038\/ng.2900.","journal-title":"Nat Genet"},{"issue":"6160","key":"6286_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, Vadas O, Gar\u00e7on F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866\u201371. https:\/\/doi.org\/10.1126\/science.1243292.","journal-title":"Science"},{"key":"6286_CR5","unstructured":"Sacco KA, Uzel G, Activated. PI3K delta syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993\u2013. 2025 Jan 30 [cited 2025 Sep 12]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK611655\/"},{"issue":"August","key":"6286_CR6","first-page":"1","volume":"9","author":"B Rivalta","year":"2021","unstructured":"Rivalta B, Amodio D, Milito C, Chiriaco M, Di Cesare S, Giancotta C. \u0648\u0622\u062e. Case report: EBV chronic infection and lymphoproliferation in four APDS patients: the challenge of proper Characterization, therapy, and Follow-Up. Front Pediatr. 2021;9(August):1\u201312.","journal-title":"Front Pediatr"},{"issue":"5","key":"6286_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1744-313X.2006.00627.x","volume":"33","author":"ST Jou","year":"2006","unstructured":"Jou ST, Chien YH, Yang YH, Wang TC, Shyur SD, Chou CC, \u0648\u0622\u062e. Identification of variations in the human phosphoinositide 3-kinase p110\u03b4 gene in children with primary B-cell immunodeficiency of unknown aetiology. Int J Immunogenet. 2006;33(5):361\u20139.","journal-title":"Int J Immunogenet"},{"issue":"1","key":"6286_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-024-01835-1","volume":"45","author":"F Barzaghi","year":"2025","unstructured":"Barzaghi F, Moratti M, Panza G, Rivalta B, Giardino G, De Rosa A, \u0648\u0622\u062e. Report of the Italian cohort with activated phosphoinositide 3-Kinase \u03b4 syndrome in the target therapy era. J Clin Immunol \u0627\u0646\u062a\u0631\u0646\u062a]. 2025;45(1):1\u201314. https:\/\/doi.org\/10.1007\/s10875-024-01835-1. \u0645\u0648\u062c\u0648\u062f \u0641\u064a.","journal-title":"J Clin Immunol \u0627\u0646\u062a\u0631\u0646\u062a]"},{"issue":"December","key":"6286_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2018.00410","volume":"6","author":"MN Pham","year":"2018","unstructured":"Pham MN, Cunningham-Rundles C. Evaluation of lymphoproliferative disease and increased risk of lymphoma in activated phosphoinositide 3 kinase delta syndrome: A case report with discussion. Front Pediatr. 2018;6(December):1\u20137. https:\/\/doi.org\/10.3389\/fped.2018.00410.","journal-title":"Front Pediatr"},{"issue":"9","key":"6286_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood.2019002072","volume":"135","author":"A Durandy","year":"2020","unstructured":"Durandy A, Kracker S. Increased activation of PI3 kinase-\u03b4 predisposes to B-cell lymphoma. Blood [\u0627\u0646\u062a\u0631\u0646\u062a]. 2020;135(9):638\u201343. https:\/\/doi.org\/10.1182\/blood.2019002072. \u0645\u0648\u062c\u0648\u062f \u0641\u064a:.","journal-title":"Blood [\u0627\u0646\u062a\u0631\u0646\u062a]"},{"issue":"4","key":"6286_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2023.06.015","volume":"152","author":"ME Maccari","year":"2023","unstructured":"Maccari ME, Wolkewitz M, Schwab C, Lorenzini T, Leiding JW, Aladjdi N, \u0648\u0622\u062e. Activated phosphoinositide 3-kinase \u03b4 syndrome: update from the ESID registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. J Allergy Clin Immunol. 2023;152(4):984\u2013e99610.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"6286_CR12","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1016\/j.jaip.2021.07.044","volume":"9","author":"J Oh","year":"2021","unstructured":"Oh J, Garabedian E, Fuleihan R, Cunningham-Rundles C. Clinical manifestations and outcomes of activated phosphoinositide 3-Kinase \u03b4 syndrome from the USIDNET cohort. J Allergy Clin Immunol Pract [\u0627\u0646\u062a\u0631\u0646\u062a]. 2021;9(11):4095\u2013102. https:\/\/doi.org\/10.1016\/j.jaip.2021.07.044. \u0645\u0648\u062c\u0648\u062f \u0641\u064a.","journal-title":"J Allergy Clin Immunol Pract [\u0627\u0646\u062a\u0631\u0646\u062a]"},{"issue":"2","key":"6286_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, \u0648\u0622\u062e. Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: A large patient cohort study. J Allergy Clin Immunol. 2017;139(2):597\u2013e6064.","journal-title":"J Allergy Clin Immunol"},{"issue":"SEP","key":"6286_CR14","first-page":"1","volume":"9","author":"TI Coulter","year":"2018","unstructured":"Coulter TI, Cant AJ. The treatment of activated PI3Kd syndrome. Front Immunol. 2018;9(SEP):1\u20135.","journal-title":"Front Immunol"},{"issue":"2","key":"6286_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cei.12706","volume":"183","author":"M Elgizouli","year":"2016","unstructured":"Elgizouli M, Lowe DM, Speckmann C, Schubert D, H\u00fclsd\u00fcnker J, Eskandarian Z, \u0648\u0622\u062e. Activating PI3K\u03b4 mutations in a cohort of 669 patients with primary immunodeficiency. Clin Exp Immunol. 2016;183(2):221\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"6286_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gendis.2019.09.015","volume":"7","author":"A Singh","year":"2020","unstructured":"Singh A, Joshi V, Jindal AK, Mathew B, Rawat A. An updated review on activated PI3 kinase delta syndrome (APDS). Genes Dis [\u0627\u0646\u062a\u0631\u0646\u062a]. 2020;7(1):67\u201374. https:\/\/doi.org\/10.1016\/j.gendis.2019.09.015. \u0645\u0648\u062c\u0648\u062f \u0641\u064a.","journal-title":"Genes Dis [\u0627\u0646\u062a\u0631\u0646\u062a]"},{"issue":"1","key":"6286_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, \u0648\u0622\u062e. Clinical and Immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: A cohort study. J Allergy Clin Immunol. 2016;138(1):210\u2013e2189.","journal-title":"J Allergy Clin Immunol"},{"issue":"MAR","key":"6286_CR18","first-page":"1","volume":"9","author":"ME Maccari","year":"2018","unstructured":"Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, \u0648\u0622\u062e. Disease evolution and response to Rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European society for immunodeficiencies-activated phosphoinositide 3-kinase \u03b4 syndrome registry. Front Immunol. 2018;9(MAR):1\u20138.","journal-title":"Front Immunol"},{"issue":"9","key":"6286_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/blood.2022018546","volume":"141","author":"VK Rao","year":"2023","unstructured":"Rao VK, Webster S, \u0160ediv\u00e1 A, Plebani A, Schuetz C, Shcherbina A. \u0648\u0622\u062e. A randomized, placebo-controlled phase 3 trial of the PI3K\u03b4 inhibitor Leniolisib for activated PI3K\u03b4 syndrome. Blood. 2023;141(9):971\u201383.","journal-title":"Blood"},{"issue":"January","key":"6286_CR20","first-page":"1","volume":"15","author":"F Conti","year":"2024","unstructured":"Conti F, Moratti M, Sabattini E, Zinzani PL. Expert insights on hodgkin\u2019s lymphoma development in an activated PI3K delta syndrome patient undergoing Leniolisib treatment. Front Immunol. 2024;15(January):1\u20137.","journal-title":"Front Immunol"},{"issue":"6","key":"6286_CR21","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jaci.2022.08.024","volume":"150","author":"MJ Gutierrez","year":"2022","unstructured":"Gutierrez MJ, Nino G, Sun D, Restrepo-Gualteros S, Sadreameli SC, Fiorino EK, \u0648\u0622\u062e. The lung in inborn errors of immunity: from clinical disease patterns to molecular pathogenesis. J Allergy Clin Immunol. 2022;150(6):1314\u201324.","journal-title":"J Allergy Clin Immunol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06286-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:42:32Z","timestamp":1762166552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-06286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6286"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06286-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Human research Ethics Committee USM (JEPeM), USM\/JEPeM\/22090600.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written informed consent for publication has been obtained from the parent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"898"}}